The prolyl isomerase PIN1: A pivotal new twist in phosphorylation signalling and disease

Nature Reviews Molecular Cell Biology

Volumn 8, Issue 11, 2007, Pages 904-916

  Lu, Kun Ping ^a   Zhou, Xiao Zhen ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOMERASE; PROLYL ISOMERASE PIN1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ASTHMA; CATALYSIS; CELL CYCLE; CELL GROWTH; CELL STRESS; CELL SURVIVAL; ENZYME PHOSPHORYLATION; IMMUNE RESPONSE; NERVE CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CATALYSIS; CELL CYCLE; DISEASE; HUMANS; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 35448945269     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2261     Document Type: Review

References (149)

1. Pawson, T. & Scott, J. D. Protein phosphorylation in signaling - 50 years and counting. Trends Biochem. Sci. 30, 286-290 (2005).
2. Blume-Jensen, P. & Hunter, T. Oncogenic kinase signalling. Nature 411, 355-365 (2001).
3. Nigg, E. A. Mitotic kinases as regulators of cell division and its checkpoints. Nature Rev. Mol. Cell Biol. 2, 21-32 (2001).
4. Lee, M. S. & Tsai, L. H. Cdk5: one of the links between senile plaques and neurofibrillary tangles? J. Alzheimers Dis. 5, 127-137 (2003).
5. Lu, K. P., Liou, Y. C. & Vincent, I. Proline-directed phosphorylation and isomerization in mitotic regulation and in Alzheimer's disease. BioEssays 25, 174-181 (2003).
6. Lu, K. P. Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem. Sci. 29, 200-209 (2004).
7. Wulf, G., Finn, G., Suizu, F. & Lu, K. P. Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nature Cell Biol. 7, 435-441 (2005).
8. Lu, K. P., Hanes, S. D. & Hunter, T. A human peptidylprolyl isomerase essential for regulation of mitosis. Nature 380, 544-547 (1996). Describes the discovery of PIN1 as one of three proteins that interact with NIMA to suppress its lethal mitotic phenotype, and shows that PIN1 is the first active peptidyl-prolyl isomerase that is essential for cell division in budding yeast.
9. Yaffe, M. B. et al. Sequence-specific and phosphorylation- dependent proline isomerization: a potential mitotic regulatory mechanism. Science 278, 1957-1960 (1997).
10. Ranganathan, R., Lu, K. P., Hunter, T. & Noel, J. P. Structural and functional analysis of the mitotic peptidyl-prolyl isomerase Pin1 suggests that substrate recognition is phosphorylation dependent. Cell 89, 875-886 (1997). References 9 and 10 describe the first identification of PIN1 as a phosphorylation-specific prolyl isomerase and PIN1 substrates.
11. Fischer, G. & Aumuller, T. Regulation of peptide bond cis/transisomerization by enzyme catalysis and its implication in physiological processes. Rev. Physiol. Biochem. Pharmacol. 148, 105-150 (2003).
12. Lu, P. J., Zhou, X. Z., Shen, M. & Lu, K. P. A function of WW domains as phosphoserine- or phosphothreoninebinding modules. Science 283, 1325-1328 (1999). Describes the PIN1 WW domain as the first phosphoSer- or phosphoThr-binding module to be discovered after phosphoSer- or phosphoThrbinding 14-3-3 proteins.
13. Zhou, X. Z., Lu, P. J., Wulf, G. & Lu, K. P. Phosphorylation- dependent prolyl isomerization: a novel signaling regulatory mechanism. Cell. Mol. Life Sci. 56, 788-806 (1999).
14. Atchison, F. W. & Means, A. R. A role for Pin1 in mammalian germ cell development and spermatogenesis. Front. Biosci. 9, 3248-3256 (2004).
15. Anderson, P. Pin1: a proline isomerase that makes you wheeze? Nature Immunol. 6, 1211-1212 (2005).
16. Maudsley, S. & Mattson, M. P. Protein twists and turns in Alzheimer disease. Nature Med. 12, 392-393 (2006).
17. Butterfield, D. A. et al. Pin1 in Alzheimer's disease. J. Neurochem. 98, 1697-1706 (2006).
18. Goutagny, N., Severa, M. & Fitzgerald, K. A. Pin-ning down immune responses to RNA viruses. Nature Immunol. 7, 555-557 (2006).
19. Hajnoczky, G. & Hoek, J. B. Cell signaling. Mitochondrial longevity pathways. Science 315, 607-609 (2007).
20. Shaw, P. E. Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail? EMBO Rep. 8, 40-45 (2007).
21. Balastik, M., Lim, J., Pastorino, L. & Lu, K. P. Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanisms? Biophys. Biochem. Acta 1772, 422-429 (2007).
22. Avila, M. A. & Lu, K. P. Hepatitis B virus X-protein and Pin1 in liver cancer: "Les liaisons dangereuses". Gastroenterology 132, 1088-1103 (2007).
23. Yeh, E. S. & Means, A. R. PIN1, the cell cycle and cancer. Nature Rev. Cancer 7, 381-388 (2007).
24. Andreotti, A. H. Native state proline isomerization: an intrinsic molecular switch. Biochemistry 42, 9515-9524 (2003).
25. Eckert, B., Martin, A., Balbach, J. & Schmid, F. X. Prolyl isomerization as a molecular timer in phage infection. Nature Struct. Mol. Biol. 12, 619-623 (2005).
26. Lummis, S. C. et al. Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. Nature 438, 248-252 (2005).
27. Nelson, C. J., Santos-Rosa, H. & Kouzarides, T. Proline isomerization of histone H3 regulates lysine methylation and gene expression. Cell 126, 905-916 (2006).
28. Sarkar, P., Reichman, C., Saleh, T., Birge, R. B. & Kalodimos, C. G. Proline cis-trans isomerization controls autoinhibition of a signaling protein. Mol. Cell 25, 413-426 (2007).
29. Nicholson, L. K. & Lu, K. P. Prolyl cis-trans isomerization as a molecular timer in Crk signaling. Mol. Cell 25, 483-485 (2007).
30. Lu, K. P., Finn, G., Lee, T. H. & Nicholson, L. K. Prolyl cis-trans isomerization as a molecular timer. Nature Chem. Biol. (in the press).
31. Weiwad, M., Kullertz, G., Schutkowski, M. & Fischer, G. Evidence that the substrate backbone conformation is critical to phosphorylation by p42 MAP kinase. FEBS Lett. 478, 39-42 (2000).
32. Brown, N. R., Noble, M. E., Endicott, J. A. & Johnson, L. N. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nature Cell Biol. 1, 438-443 (1999).
33. Zhou, X. Z. et al. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 6, 873-883 (2000).
34. Kipping, M. et al. Increased backbone flexibility in threonine45-phosphorylated hirudin upon pH change. Biochemistry 40, 7957-7963 (2001).
35. Dolinski, K., Muir, S., Cardenas, M. & Heitman, J. All cyclophilins and FKBPs are dispensible for viability in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 94, 13093-13098 (1997).
36. Joseph, J. D., Daigle, S. N. & Means, A. R. PINA is essential for growth and positively influences NIMA function in Aspergillus nidulans. J. Biol. Chem. 279, 32373-32384 (2004).
37. Devasahayam, G., Chaturvedi, V. & Hanes, S. D. The Ess1 prolyl isomerase is required for growth and morphogenetic switching in Candida albicans. Genetics 160, 37-48 (2002).
38. Huang, H. K., Forsburg, S. L., John, U. P., O'Connell, M. J. & Hunter, T. Isolation and characterization of the Pin1/Ess1p homologue in Schizosaccharomyces pombe. J. Cell Sci. 114, 3779-3788 (2001).
39. Fujimori, F., Takahashi, K., Uchida, C. & Uchida, T. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem. Biophys. Res. Commun. 265, 658-663 (1999). Describes the first generation of Pin1-deficient mice, but reports that they have no phenotype, which has subsequently been found to be incorrect.
40. Arevalo-Rodriguez, M., Cardenas, M. E., Wu, X., Hanes, S. D. & Heitman, J. Cyclophilin A and Ess1 interact with and regulate silencing by the Sin3-Rpd3 histone deacetylase. EMBO J. 19, 3739-3749 (2000).
41. Fujimori, F. et al. Crosstalk of prolyl isomerases, Pin1/Ess1, and cyclophilin A. Biochem. Biophys. Res. Commun. 289, 181-190 (2001).
42. Yao, J. L., Kops, O., Lu, P. J. & Lu, K. P. Functional conservation of phosphorylation-specific prolyl isomerases in plants. J. Biol. Chem. 276, 13517-13523 (2001).
43. Zhu, J. X., Dagostino, E., Rejto, P. A., Mroczkowski, B. & Murray, B. Identification and characterization of a novel and functional murine Pin1 isoform. Biochem. Biophys. Res. Commun. 359, 529-535 (2007).
44. Lu, P. J., Wulf, G., Zhou, X. Z., Davies, P. & Lu, K. P. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399, 784-788 (1999). Identifies tau as the first PIN1 substrate in neurons and finds that PIN1 is depleted in Alzheimer's brains, providing the first link between PIN1 and Alzheimer's disease.
45. Wulf, G. M. et al. Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene. EMBO J. 20, 3459-3472 (2001).
46. Ryo, A., Nakamura, N., Wulf, G., Liou, Y. C. & Lu, K. P. Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC. Nature Cell Biol. 3, 793-801 (2001). References 45 and 46 are the first demonstrations of PIN1 overexpression in human cancers and its crucial role in activating Ras/JNK/c-Jun and Wnt/β-catenin oncogenic pathways.
47. Liou, Y. C. et al. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. USA 99, 1335-1340 (2002). Describes the first obvious set of cell proliferative phenotypes in Pin1-deficient mice.
48. Ryo, A. et al. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitinmediated proteolysis of p65/RelA. Mol. Cell 12, 1413-1426 (2003).
49. Verdecia, M. A., Bowman, M. E., Lu, K. P., Hunter, T. & Noel, J. P. Structural basis for phosphoserine-proline recognition by group IV WW domains. Nature Struct. Biol. 7, 639-643 (2000).
50. Wintjens, R. et al. 1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides. J. Biol. Chem. 276, 25150-25156. (2001).
51. Jacobs, D. M. et al. Peptide binding induces large scale changes in inter-domain mobility in human Pin1. J. Biol. Chem. 278, 26174-26182 (2003).
52. Smet, C., Wieruszeski, J. M., Buee, L., Landrieu, I. & Lippens, G. Regulation of Pin1 peptidyl-prolyl cis/trans isomerase activity by its WW binding module on a multi-phosphorylated peptide of Tau protein. FEBS Lett. 579, 4159-4164 (2005).
53. Pastorino, L. et al. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production. Nature 440, 528-534 (2006). Provides the first direct demonstration of the dynamic conformational regulation after phosphorylation by PIN1 using NMR and describes that PIN1 deregulation might contribute to both tangle and plaque pathologies in Alzheimer's disease.
54. Namanja, A. T. et al. Substrate recognition reduces side-chain flexibility for conserved hydrophobic residues in human PIN1. Structure 15, 313-327 (2007).
55. Peng, T., Zintsmaster, J. S., Namanja, A. T. & Peng, J. W. Sequence-specific dynamics modulate recognition specificity in WW domains. Nature Struct. Mol. Biol. 14, 325-331 (2007).
56. Labeikovsky, W., Eisenmesser, E. Z., Bosco, D. A. & Kern, D. Structure and dynamics of pin1 during catalysis by NMR. J. Mol. Biol. 367, 1370-1381 (2007).
57. Ramelot, T. A. & Nicholson, L. K. Phosphorylation-induced structural changes in the amyloid precursor protein cytoplasmic tail detected by NMR. J. Mol. Biol. 307, 871-884 (2001).
58. Lu, P. J., Zhou, X. Z., Liou, Y. C., Noel, J. P. & Lu, K. P. Critical role of WW domain phosphorylation in regulating its phosphoserine-binding activity and the Pin1 function. J. Biol. Chem. 277, 2381-2384 (2002).
59. Liou, Y.-C. et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 424, 556-561 (2003).
60. Hamdane, M. et al. Pin1 allows for differential Tau dephosphorylation in neuronal cells. Mol. Cell. Neurosci. 32, 155-160 (2006).
61. Bao, L., Sauter, G., Sowadski, J., Lu, K. P. & Wang, D. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 164, 1727-1737 (2004).
62. Atchison, F. W., Capel, B. & Means, A. R. Pin1 regulates the timing of mammalian primordial germ cell proliferation. Development 130, 3579-3586 (2003).
63. Ryo, A. et al. Pin1 is an E2F target gene essential for the Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell Biol. 22, 5281-5295 (2002).
64. MacLachlan, T. K. et al. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J. Biol. Chem. 275, 2777-2785 (2000).
65. Eckerdt, F. et al. Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J. Biol. Chem. 280, 36575-36583 (2005).
66. Sultana, R. et al. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis. Neurobiol. Aging 27, 918-925 (2006).
67. Butterfield, D. A. et al. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol. Dis. 22, 223-232 (2006).
68. Shen, M., Stukenberg, P. T., Kirschner, M. W. & Lu, K. P. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 12, 706-720 (1998).
69. Crenshaw, D. G., Yang, J., Means, A. R. & Kornbluth, S. The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. EMBO J. 17, 1315-1327 (1998).
70. Winkler, K. E., Swenson, K. I., Kornbluth, S. & Means, A. R. Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 287, 1644-1647 (2000).
71. Stukenberg, P. T. & Kirschner, M. W. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol. Cell 7, 1071-1083 (2001).
72. Ubersax, J. A. et al. Targets of the cyclin-dependent kinase Cdk1. Nature 425, 859-864 (2003).
73. Okamoto, K. & Sagata, N. Mechanism for inactivation of the mitotic inhibitory kinase Wee1 at M phase. Proc. Natl Acad. Sci. U S. A 104, 3753-3758 (2007).
74. Bernis, C. et al. Pin1 stabilizes Emi1 during G2 phase by preventing its association with SCF(betatrcp). EMBO Rep. 8, 91-98 (2007).
75. Xu, Y. X. & Manley, J. L. The prolyl isomerase pin1 functions in mitotic chromosome condensation. Mol. Cell 26, 287-300 (2007).
76. Yeh, E. et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nature Cell Biol. 6, 308-318 (2004). Describes MYC as a PIN1 substrate with MYC being more stable in Pin1-deficient embryonic fibroblasts. This suggests that loss of PIN1 may be oncogenic, although other studies show that loss of PIN1 in mice prevents cancer development induced either by overexpression of oncogenic Neu or Ras, or by knockout of p53.
77. van Drogen, F. et al. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. Mol. Cell 23, 37-48 (2006).
78. Suizu, F., Ryo, A., Wulf, G., Lim, J. & Lu, K. P. Pin1 regulates centrosome duplication and its overexpression induces centrosome amplification, chromosome instability and oncogenesis. Mol. Cell Biol. 26, 1463-1479 (2006).
79. Nigg, E. A. Centrosome aberrations: cause or consequence of cancer progression? Nature Rev. Cancer 2, 815-825. (2002).
80. Doxsey, S., McCollum, D. & Theurkauf, W. Centrosomes in cellular regulation. Annu. Rev. Cell Dev. Biol. 21, 411-434 (2005).
81. Lu, K. P. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell 4, 175-180 (2003).
82. Lu, K. P. et al. Targeting carcinogenesis: a role for the prolyl isomerase Pin1? Mol. Carcinog. 45, 397-402 (2006).
83. Chen, S. Y. et al. Activation of β-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-β-catenin interaction. Mol. Cell Biol. 26, 929-939 (2006).
84. Dougherty, M. K. et al. Regulation of Raf-1 by direct feedback phosphorylation. Mol. Cell 17, 215-224 (2005).
85. Wulf, G., Garg, P., Liou, Y. C., Iglehart, D. & Lu, K. P. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J. 23, 3397-3407 (2004).
86. Yu, Q., Geng, Y. & Sicinski, P. Specific protection against breast cancers by cyclin D1 ablation. Nature 411, 1017-1021 (2001).
87. Lufei, C., Koh, T. H., Uchida, T. & Cao, X. Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity. Oncogene (in the press).
88. Pang, R. et al. PIN1 overexpression and β-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma. Oncogene 23, 4182-4186 (2004).
89. Yeh, E. S., Lew, B. O. & Means, A. R. The loss of PIN1 deregulates cyclin E and sensitizes MEFs to genomic instability. J. Biol. Chem. 281, 241-251 (2006).
90. Takahashi, K. et al. Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1. Oncogene 26, 3835-3845 (2007).
91. Toledo, F. et al. Mouse mutants reveal that putative protein interaction sites in the p53 proline-rich domain are dispensable for tumor suppression. Mol. Cell Biol. 27, 1425-1432 (2007).
92. Roux, P. P. & Blenis, J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344 (2004).
93. Karin, M. & Gallagher, E. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57, 283-295 (2005).
94. Wulf, G. M., Liou, Y. C., Ryo, A., Lee, S. W. & Lu, K. P. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 277, 47976-47979 (2002).
95. Zheng, H. et al. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 419, 849-853 (2002).
96. Zacchi, P. et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 419, 853-857 (2002). References 94-96 identify p53 as a PIN1 substrate in response to genotoxic stress.
97. Mantovani, F. et al. Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol. Cell 14, 625-636 (2004).
98. Shc. Science 315, 659-663 (2007).
99. shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309-313 (1999).
100. Moretto Zita, M. et al. Post-phosphorylation prolyl isomerisation of gephyrin represents a mechanism to modulate glycine receptors function. EMBO J. 26, 1761-1771 (2007).
101. Li, Q. M. et al. Activation of JNK3 after injury induces cytochrome C release by facilitating Pin1-dependent degradation of Mcl-1. J. Neurosci. 27, 8395-8404 (2007).
102. Becker, E. B. & Bonni, A. Pin1 mediates neural-specific activation of the mitochondrial apoptotic machinery. Neuron 49, 655-662 (2006).
103. Lee, V. M., Goedert, M. & Trojanowski, J. Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159 (2001).
104. Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
105. Mattson, M. P. Pathways towards and away from Alzheimer's disease. Nature 430, 631-639 (2004).
106. Tanzi, R. E. & Bertram, L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120, 545-555 (2005).
107. Goedert, M. & Spillantini, M. G. A century of Alzheimer's disease. Science 314, 777-781 (2006).
108. Webber, K. M. et al. The cell cycle in Alzheimer disease: a unique target for neuropharmacology. Mech. Ageing Dev. 126, 1019-1025 (2005).
109. Yang, Y. & Herrup, K. Cell division in the CNS: protective response or lethal event in post-mitotic neurons? Biochim. Biophys. Acta 1772, 457-466 (2007).
110. Lee, M. S. et al. APP processing is regulated by cytoplasmic phosphorylation. J. Cell Biol. 163, 83-95 (2003).
111. Thorpe, J. R., Morley, S. J. & Rulten, S. L. Utilizing the peptidyl-prolyl cis-trans isomerase pin1 as a probe of its phosphorylated target proteins. Examples of binding to nuclear proteins in a human kidney cell line and to tau in Alzheimer's diseased brain. J. Histochem. Cytochem. 49, 97-108 (2001).
112. Ramakrishnan, P., Dickson, D. W. & Davies, P. Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. Neurobiol. Dis. 14, 251-264 (2003).
113. Thorpe, J. R. et al. Shortfalls in the peptidyl-prolyl cis-trans isomerase protein Pin1 in neurons are associated with frontotemporal dementias. Neurobiol. Dis. 17, 237-249 (2004).
114. Wang, S. et al. The significance of Pin1 in the development of Alzheimer's disease. J. Alzheimers Dis. 11, 13-23 (2007).
115. Davies, D. C., Horwood, N., Isaacs, S. L. & Mann, D. M. The effect of age and Alzheimer's disease on pyramidal neuron density in the individual fields of the hippocampal formation. Acta Neuropathol. (Berl.) 83, 510-517 (1992).
116. Campbell, H. D., Webb, G. C., Fountain, S. & Young, I. G. The human PIN1 peptidyl-prolyl cis/trans isomerase gene maps to human chromosome 19p13 and the closely related PIN1L gene to 1p31. Genomics 44, 157-162 (1997).
117. Wijsman, E. M. et al. Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. Am. J. Hum. Genet. 75, 398-409 (2004).
118. Segat, L. et al. Pin1 promoter polymorphisms are associated with Alzheimer's disease. Neurobiol. Aging 28, 69-74 (2007).
119. Lambert, J. C., Bensemain, F., Chapuis, J., Cottel, D. & Amouyel, P. Association study of the PIN1 gene with Alzheimer's disease. Neurosci. Lett. 402, 259-261 (2006).
120. Nowotny, P. et al. Association studies between common variants in prolyl isomerase Pin1 and the risk for late-onset Alzheimer's disease. Neurosci. Lett. 419, 15-17 (2007).
121. Ishihara, T. et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24, 751-762 (1999).
122. Lewis, J. et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nature Genet. 25, 402-405 (2000).
123. Gotz, J., Chen, F., van Dorpe, J. & Nitsch, R. M. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Aβ 42 fibrils. Science 293, 1491-1495 (2001).
124. Lewis, J. et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491 (2001).
125. Cruz, J. C., Tseng, H. C., Goldman, J. A., Shih, H. & Tsai, L. H. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483 (2003).
126. Akiyama, H., Shin, R. W., Uchida, C., Kitamoto, T. & Uchida, T. Pin1 promotes production of Alzheimer's amyloid β from β-cleaved amyloid precursor protein. Biochem. Biophys. Res. Commun. 336, 521-529 (2005).
127. Takahashi, R. H. et al. Intraneuronal Alzheimer aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161, 1869-1879 (2002).
128. Wong, P. C., Cai, H., Borchelt, D. R. & Price, D. L. Genetically engineered mouse models of neurodegenerative diseases. Nature Neurosci. 5, 633-639 (2002).
129. Roe, C. M., Behrens, M. I., Xiong, C., Miller, J. P. & Morris, J. C. Alzheimer disease and cancer. Neurology 64, 895-898 (2005).
130. Jicha, G. A. et al. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J. Neurochem. 69, 2087-2095 (1997).
131. Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-κB in cancer: from innocent bystander to major culprit. Nature Rev. Cancer 2, 301-310 (2002).
132. Monje, P., Hernandez-Losa, J., Lyons, R. J., Castellone, M. D. & Gutkind, J. S. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J. Biol. Chem. 280, 35081-35084 (2005).
133. Shaulian, E. & Karin, M. AP-1 as a regulator of cell life and death. Nature Cell Biol. 4, E131-E136 (2002).
134. Karin, M. & Greten, F. R. NF-κB: linking inflammation and immunity to cancer development and progression. Nature Rev. Immunol. 5, 749-759 (2005).
135. Shen, Z. J., Esnault, S. & Malter, J. S. The peptidylprolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils. Nature Immunol. 6, 1280-1287 (2005). Describes that PIN1 is activated in asthma and that it has a crucial role in granulocyte-macrophage colony-stimulating factor production and eosinophil survival.
136. Saitoh, T. et al. Negative regulation of interferonregulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nature Immunol. 7, 598-605 (2006).
137. Yu, L. et al. Regulation of Bruton's tyrosine kinase (Btk) by the peptidyl-prolyl isomerase Pin1. J. Biol. Chem. 281, 18201-18207 (2006).
138. Orlicky, S., Tang, X., Willems, A., Tyers, M. & Sicheri, F. Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell 112, 243-256 (2003).
139. Schreiber, S. L. & Crabtree, G. R. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13, 136-142 (1992).
140. Ayala, G. et al. Pin1 is a novel prognostic marker in prostate cancer. Cancer Research 63, 6244-6251 (2003).
141. Kuramochi, J. et al. High Pin1 expression is associated with tumor progression in colorectal cancer. J. Surg. Oncol. 94, 155-160 (2006).
142. He, J. et al. Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases. Lung Cancer 56, 51-58 (2007).
143. Pang, R. et al. Pin1 interacts with a specific serineproline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 132, 1088-1103 (2007).
144. Hennig, L. et al. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 37, 5953-5960 (1998).
145. Uchida, T. et al. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem. Biol. 10, 15-24 (2003).
146. Wang, X. J., Xu, B., Mullins, A. B., Neiler, F. K. & Etzkorn, F. A. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere. J. Am. Chem. Soc. 126, 15533-15542 (2004).
147. Wildemann, D. et al. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries. J. Med. Chem. 49, 2147-2150 (2006).
148. Zhang, Y. et al. Structural basis for high-affinity peptide inhibition of human Pin1. ACS Chem. Biol. 2, 320-328 (2007).
149. Formichi, P., Battisti, C., Radi, E. & Federico, A. Cerebrospinal fluid tau, A β, and phosphorylated tau protein for the diagnosis of Alzheimer's disease. J. Cell Physiol. 208, 39-46 (2006).